coronavirus

Signal: Project NextGen continues with $500m funding for vaccine research

US Covid-19 research initiative Project NextGen is continuing apace, announcing on Friday (13 October) that the Department for Health and…

eFFECTOR reports positive data from trial of zotatifin for Covid-19

eFFECTOR Therapeutics has reported positive top-line data from its Phase Ib clinical trial of zotatifin to treat Covid-19. The potent…

GeoVax and EmVenio partner for clinical facility to expand Covid-19 trial

GeoVax Labs and decentralised trial global organisation EmVenio Research have announced a partnership for the deployment of a mobile clinical…

GreenLight receives Rwanda FDA approval for Covid-19 mRNA vaccine trial

GreenLight Biosciences has received the Rwanda Food and Drugs Authority (Rwanda FDA) approval for a Phase I/II clinical trial of…

Dyadic initiates subject dosing in Phase I trial of Covid-19 booster

Dyadic International has initiated subject dosing in its Phase I clinical trial of the Covid-19 recombinant protein receptor binding domain…

Tevogen Bio reports positive data from Covid-19 T cell therapy trial

Tevogen Bio has reported positive topline data from a clinical trial of off-the-shelf, allogeneic cytotoxic CD8+ T cell therapy TVGN…

Ascletis doses subjects in first cohort of Covid-19 oral therapy trial

Ascletis Pharma has dosed the first cohort’s four healthy participants in a Phase I clinical trial of its oral therapy…

American CryoStem to proceed with Phase I Covid-19 cell therapy trial

American CryoStem is set to proceed with a Phase I clinical trial of its ATCELL therapy to treat Long Covid/PASC,…

Meiji Seika Pharma commences Phase III mRNA Covid-19 vaccine trial in Japan

Meijisubsidiary Meiji Seika Pharma has commenced a Phase III clinical trial of a messenger ribonucleic acid (mRNA) vaccine, ARCT-154, for…

Ascletis reports positive data from Phase I Covid-19 prodrug trial

Ascletis Pharma has reported positive topline data from the Phase I multiple ascending dose (MAD) clinical trial of its prodrug, ASC10, in…